Updates to Tempo’s Manufacturing Execution System and Connected Manufacturing Network Drive Greater Efficiency and Scalability
JERSEY CITY, NJ / ACCESSWIRE / August 15, 2023 / Apprentice, which helps life science manufacturers get treatments to patients faster by providing one platform to turn molecules into medicine, announced today a major release to its Tempo Manufacturing Cloud, focused on extending product capabilities for modern commercial manufacturing.
The 7.0 Release deepens Tempo’s existing features in its Manufacturing Execution System (MES) that support commercial production and adds a new product, the Connected Manufacturing Network (CMN), that creates a connected digital network across internal and external sites.
Deepening Manufacturing Execution System (MES) Capabilities
“We want to help our customers navigate today’s complex manufacturing environment as drug therapies become more specialized and scalability becomes more important,” said Angelo Stracquatanio, CEO & Co-founder of Apprentice.io. “With the 7.0 release, we’re building the technological innovation that will directly reduce cost, increase speed, and maximize yield of commercial manufacturing so that lifesaving medicines get to patients in need.”
In addition to 30+ new features and enhancements, seven key new capabilities standout:
The Connected Manufacturing Network
The 7.0 release also includes the new CMN product. Tempo’s CMN enables you to drive value at the site-level, the enterprise-level, and across external partners. To achieve this, CMN brings together four powerful capabilities:
These key tools allow you to coordinate the materials, equipment, recipes, and personnel needed to plan, execute, test, and release a batch from one shared system to accelerate the end-to-end drug production lifecycle.
Launching Tempo with the Team
Apprentice held a virtual launch event on Tuesday with 100+ attendees highlighting the new commercial functionality and the success of its recently released CMN package.
Event sessions covered everything from Apprentice’s more sophisticated commercial manufacturing capabilities to its new quarterly release cadence, additional quality updates, and the formation of its partner program.
“We have a clear vision for building a product that can support the future of commercial manufacturing and connect enterprise-wide operations across internal and external sites and teams,” said Jean Barmash, CTO at Apprentice. “We will continue to up-level our product capabilities and standardize our approach so that our customers can rely on one system for accelerating critical drug production.”
About Apprentice
Apprentice helps life science manufacturers get therapeutics to patients faster by providing one platform to turn molecules into medicine. Our Tempo Manufacturing Cloud accelerates the end-to-end drug product lifecycle by connecting together distributed teams and sites, helping them execute better on the shop floor, and optimizing their operations through enterprise-wide visibility. From preclinical benchtop to large-scale commercial manufacturing, Tempo keeps your global teams connected, empowered, and in sync.
With $207M in funding, a 3.4x growth YoY rate, and 218% net customer retention, Apprentice is a trusted partner to modernize your operations and change the way drugs are made in your facility. Learn how leading companies like Synthego and Bristol Myers Squibb are using Tempo to scale from drug discovery to patient delivery faster at www.apprentice.io.
Contact Information
Kristen Kucks
Director of Communications, Marketing
kristen.kucks@apprentice.io
Marie Forshaw
VP, Marketing
marie.forshaw@apprentice.io
SOURCE: Apprentice.io
View source version on accesswire.com:
https://www.accesswire.com/774308/Apprentice-Announces-Major-Tempo-Manufacturing-Cloud-Release-Built-to-Support-Commercial-Manufacturing-of-the-Future
DENVER, June 12, 2024 /PRNewswire/ -- Momcozy, a leading provider of maternity products and nursing…
NEW YORK, June 12, 2024 /PRNewswire/ -- The global X-ray equipment market size is estimated…
SCHAFFHAUSEN, Switzerland, June 12, 2024 /PRNewswire/ -- The shareholders of TE Connectivity Ltd. (NYSE: TEL) approved…
MARIETTA, Ga., June 12, 2024 /PRNewswire/ -- BRIJ Medical is proud to announce that it…
Donald Trump leads over President Joe Biden among older voters; Senate race is neck-and-neck between…
SUSSEX, Wis., June 12, 2024 /PRNewswire/ -- Quad/Graphics, Inc. (NYSE: QUAD), a global marketing experience…